We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Decision Preserves Market Exclusivity Period for Generic Firms
Appeals Court Decision Preserves Market Exclusivity Period for Generic Firms
November 28, 2006
A U.S. appeals court has upheld a lower court’s ruling maintaining the 180-day marketing exclusivity period for generic drugmakers Ranbaxy Laboratories and Teva Pharmaceutical to market their versions of Merck’s Zocor, a cholesterol treatment drug that generated nearly $4.5 billion in sales for the brand company last year.